health Eli Lilly Acquires Kelonia Therapeutics for Up to $7 Billion in Cancer Therapy Push
Eli Lilly announces a major acquisition of Kelonia Therapeutics for up to $7 billion, bolstering its cell therapy pipeline with a novel in vivo cancer treatment.
